X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6646) 6646
Newsletter (55) 55
Book Chapter (38) 38
Magazine Article (25) 25
Book / eBook (11) 11
Dissertation (9) 9
Conference Proceeding (3) 3
Newspaper Article (3) 3
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4657) 4657
aminoglycosides (3250) 3250
anti-bacterial agents - therapeutic use (2502) 2502
male (1833) 1833
female (1763) 1763
aminoglycosides - therapeutic use (1722) 1722
pharmacology & pharmacy (1486) 1486
antibiotics (1441) 1441
animals (1357) 1357
microbiology (1163) 1163
anti-bacterial agents - pharmacology (1144) 1144
adult (1127) 1127
middle aged (1120) 1120
gentamicin (992) 992
aged (961) 961
infectious diseases (930) 930
anti-bacterial agents - administration & dosage (846) 846
microbial sensitivity tests (837) 837
infections (708) 708
aminoglycosides - pharmacology (697) 697
bacterial infections - drug therapy (642) 642
anti-bacterial agents - adverse effects (635) 635
treatment outcome (568) 568
health aspects (533) 533
aminoglycosides - administration & dosage (532) 532
aminoglycoside antibiotics (523) 523
adolescent (515) 515
anti-bacterial agents - pharmacokinetics (505) 505
aminoglycosides - adverse effects (491) 491
pharmacokinetics (472) 472
bacteria (471) 471
drug therapy, combination (466) 466
child (449) 449
analysis (445) 445
therapy (444) 444
aminoglycoside (443) 443
drug resistance (443) 443
gentamicins - therapeutic use (436) 436
research (414) 414
mice (401) 401
retrospective studies (399) 399
drug resistance in microorganisms (381) 381
drug resistance, microbial (376) 376
cephalosporins - therapeutic use (373) 373
vancomycin (361) 361
aged, 80 and over (356) 356
risk factors (345) 345
infant, newborn (335) 335
antimicrobial agents (334) 334
oncology (334) 334
amikacin (326) 326
nephrotoxicity (326) 326
antibacterial agents (312) 312
child, preschool (301) 301
pseudomonas infections - drug therapy (301) 301
care and treatment (300) 300
drug administration schedule (300) 300
dose-response relationship, drug (299) 299
infant (298) 298
vancomycin - therapeutic use (296) 296
drug therapy (293) 293
infection (293) 293
gentamicins - administration & dosage (290) 290
research article (284) 284
drug resistance, bacterial (279) 279
immunology (279) 279
medicine & public health (278) 278
pediatrics (277) 277
penicillins - therapeutic use (275) 275
tobramycin (275) 275
prospective studies (274) 274
resistance (272) 272
rats (265) 265
staphylococcal infections - drug therapy (264) 264
gentamicins - pharmacology (261) 261
antibodies, monoclonal, humanized (257) 257
efficacy (257) 257
pseudomonas aeruginosa - drug effects (256) 256
pseudomonas-aeruginosa (256) 256
ototoxicity (255) 255
internal medicine (253) 253
staphylococcus aureus - drug effects (245) 245
escherichia-coli (244) 244
time factors (244) 244
medicine, general & internal (242) 242
pseudomonas aeruginosa (242) 242
mortality (239) 239
cross infection - drug therapy (238) 238
drugs (235) 235
epidemiology (235) 235
genes (235) 235
toxicity (233) 233
antibiotic resistance (232) 232
anti-bacterial agents - blood (228) 228
antimicrobial resistance (228) 228
hematology (222) 222
pathogens (220) 220
clinical trials as topic (217) 217
drug therapy, combination - therapeutic use (217) 217
hospitals (216) 216
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Pharmacy (1) 1
Online Resources - Online (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6299) 6299
Japanese (192) 192
French (117) 117
German (112) 112
Russian (59) 59
Spanish (50) 50
Italian (41) 41
Polish (25) 25
Portuguese (20) 20
Chinese (15) 15
Norwegian (11) 11
Romanian (10) 10
Danish (8) 8
Hungarian (6) 6
Swedish (4) 4
Dutch (3) 3
Turkish (3) 3
Czech (2) 2
Finnish (2) 2
Arabic (1) 1
Bulgarian (1) 1
Hebrew (1) 1
Korean (1) 1
Lithuanian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Expert review of anti-infective therapy, ISSN 1744-8336, 2014, Volume 6, Issue 5, pp. 593 - 600
...; one of the most promising ones is the evaluation and use of old antibiotic compounds... 
aminoglycoside | Acinetobacter baumannii | multiple-drug resistant | fusidic acid | polymyxin B | Pseudomonas aeruginosa | chloramphenicol | fosfomycin | colistin | Colistin | Aminoglycoside | Fusidic acid | Chloramphenicol | Polymyxin B | Fosfomycin | Multiple-drug resistant | VENTILATOR-ASSOCIATED PNEUMONIA | NATURAL-PRODUCTS | RESISTANT STAPHYLOCOCCUS-AUREUS | ANTIBACTERIAL DRUG DISCOVERY | GRAM-NEGATIVE BACTERIA | INTENSIVE-CARE-UNIT | PSEUDOMONAS-AERUGINOSA | PHARMACOLOGY & PHARMACY | CYSTIC-FIBROSIS | CRITICALLY-ILL PATIENTS | TRIMETHOPRIM-SULFAMETHOXAZOLE | Fusidic Acid - administration & dosage | Humans | Drug Resistance, Bacterial | Drug Utilization | Anti-Bacterial Agents - therapeutic use | Aminoglycosides - administration & dosage | Colistin - therapeutic use | Anti-Bacterial Agents - adverse effects | Colistin - adverse effects | Fosfomycin - therapeutic use | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Bacterial Infections - drug therapy | Fosfomycin - adverse effects | Colistin - administration & dosage | Fusidic Acid - adverse effects | Chloramphenicol - therapeutic use | Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Fusidic Acid - therapeutic use | Chloramphenicol - adverse effects | Anti-Bacterial Agents - classification | Fosfomycin - administration & dosage | Aminoglycosides - adverse effects | Anti-Bacterial Agents - administration & dosage | Aminoglycosides - therapeutic use | Chloramphenicol - administration & dosage | Drug resistance in microorganisms | Pseudomonas aeruginosa infections | Usage | Antibiotics | Research | Drug therapy | Health aspects | Risk factors | Index Medicus
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2010, Volume 54, Issue 5, pp. 1742 - 1748
Journal Article
Journal of internal medicine, ISSN 0954-6820, 02/2015, Volume 277, Issue 2, pp. 155 - 166
Cystic fibrosis (CF) is the most common genetic life‐shortening condition in Caucasians. Despite being a multi‐organ disease, CF is classically diagnosed by... 
rare diseases | monogenic disorder | mutation‐specific therapies | personalized therapy | Rare diseases | Monogenic disorder | Personalized therapy | Mutation-specific therapies | CFTR MUTATIONS | GENE-MUTATIONS | PROTEIN | GENOTYPE-PHENOTYPE CORRELATIONS | F508DEL-CFTR | IDENTIFICATION | PLASMA-MEMBRANE | TRANSMEMBRANE CONDUCTANCE REGULATOR | MEDICINE, GENERAL & INTERNAL | OBSTRUCTIVE PULMONARY-DISEASE | LUNG-DISEASE | mutation-specific therapies | Severity of Illness Index | Cystic Fibrosis - blood | Frameshift Mutation | Sweat Glands - drug effects | Humans | Aminophenols - therapeutic use | Rare Diseases | Biomarkers - blood | Codon, Nonsense | Evidence-Based Medicine | Oxadiazoles - therapeutic use | Purinergic Antagonists - therapeutic use | Anti-Bacterial Agents - therapeutic use | Phenotype | Cystic Fibrosis - genetics | Quinolones - therapeutic use | Anti-Inflammatory Agents - therapeutic use | Cystic Fibrosis - diagnosis | Cystic Fibrosis Transmembrane Conductance Regulator - genetics | Genistein - therapeutic use | Cystic Fibrosis - mortality | Cystic Fibrosis - drug therapy | Aminoglycosides - therapeutic use | Precision Medicine | Cystic fibrosis | Care and treatment | Medical research | Lung diseases | Clinical trials | Mucus | Environmental factors | Patients | Defects | Proteins | Resistance | Antibiotics | Respiratory diseases | Fibrosis | Conductance | Sweat
Journal Article
Best Practice & Research: Clinical Haematology, ISSN 1521-6926, 2013, Volume 26, Issue 3, pp. 269 - 274
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2017, Volume 49, Issue 5, pp. 542 - 548
.... • Treatment of MRSA infections has revived clinical use of TMP/SMX, available both as intravenous and oral formulations... 
Infectious Disease | Multidrug-resistant | Aminoglycosides | Sulphonamides | Tetracyclines | Polymyxins | Fosfomycin | INFECTIOUS DISEASES | COMBINATION THERAPY | ANTIMICROBIAL AGENTS | INTRAVENOUS MINOCYCLINE | MICROBIOLOGY | CARBAPENEM-RESISTANT | ACINETOBACTER-BAUMANNII | GRAM-NEGATIVE BACTERIA | PSEUDOMONAS-AERUGINOSA | STAPHYLOCOCCUS-AUREUS ENDOCARDITIS | PHARMACOLOGY & PHARMACY | KLEBSIELLA-PNEUMONIAE | TRIMETHOPRIM-SULFAMETHOXAZOLE | Fosfomycin - therapeutic use | Polymyxins - therapeutic use | Fosfomycin - adverse effects | Humans | Trimethoprim - therapeutic use | Gram-Negative Bacterial Infections - drug therapy | Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Minocycline - adverse effects | Sulfamethizole - adverse effects | Trimethoprim - adverse effects | Minocycline - therapeutic use | Drug Resistance, Multiple, Bacterial | Gram-Positive Bacterial Infections - microbiology | Polymyxins - adverse effects | Sulfamethizole - therapeutic use | Anti-Bacterial Agents - adverse effects | Aminoglycosides - adverse effects | Gram-Positive Bacterial Infections - drug therapy | Drug Combinations | Aminoglycosides - therapeutic use | Drug resistance in microorganisms | Patient outcomes | Disease susceptibility | Pathogenic microorganisms | Sulfonamides | Staphylococcal infections | Mortality | Antibacterial agents | Index Medicus | Life Sciences | Human health and pathology | Infectious diseases
Journal Article
Expert review of anti-infective therapy, ISSN 1744-8336, 2014, Volume 11, Issue 4, pp. 395 - 409
Journal Article
Expert Review of Anti-infective Therapy, ISSN 1478-7210, 12/2007, Volume 5, Issue 6, pp. 961 - 981
The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) is characterized by variations (sometimes extreme) by country and geographic region. The... 
prevalence | glycopeptides | linezolid | ceftopibrole | pharmacotherapy | daptomycin | methicillin-resistant Staphylococcus aureus | vancomycin | Linezolid | Ceftopibrole | Prevalence | Methicillin-resistant Staphylococcus aureus | Daptomycin | Pharmacotherapy | Vancomycin | Glycopeptides | SOFT-TISSUE INFECTIONS | ONCE-WEEKLY DALBAVANCIN | COMPLICATED SKIN | BACTERICIDAL ACTIVITY | SKIN-STRUCTURE INFECTIONS | CARE-ASSOCIATED INFECTION | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | GRAM-POSITIVE PATHOGENS | IN-VITRO ACTIVITY | NOSOCOMIAL PNEUMONIA | Trimethoprim - pharmacology | Minocycline - pharmacology | Humans | Minocycline - analogs & derivatives | Methicillin - pharmacology | Teicoplanin - therapeutic use | Clindamycin - pharmacology | Oxazolidinones - therapeutic use | Cephalosporins - therapeutic use | Folic Acid Antagonists - therapeutic use | Anti-Bacterial Agents - therapeutic use | Acetamides - therapeutic use | Minocycline - therapeutic use | Teicoplanin - pharmacology | Sulfamethoxazole - therapeutic use | Methicillin Resistance | Cephalosporins - pharmacology | Teicoplanin - analogs & derivatives | Daptomycin - therapeutic use | Staphylococcal Infections - drug therapy | Global Health | Trimethoprim - therapeutic use | Clindamycin - therapeutic use | Glycopeptides - therapeutic use | Daptomycin - pharmacology | Staphylococcal Infections - epidemiology | Sulfamethoxazole - pharmacology | Vancomycin - therapeutic use | Doxycycline - pharmacology | Anti-Bacterial Agents - pharmacology | Aminoglycosides - pharmacology | Glycopeptides - pharmacology | Staphylococcus aureus - drug effects | Folic Acid Antagonists - pharmacology | Aminoglycosides - therapeutic use | Moxalactam | Infection | Medical research | Drug resistance in microorganisms | Cephalosporins | Staphylococcus aureus infections | Medicine, Experimental | Cephaloridine | Staphylococcus aureus | Prevalence studies (Epidemiology)
Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2010, Volume 148, Issue 2, pp. 217 - 225
Journal Article